Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 Years

Iung, Bernard; Armoiry, Xavier; Vahanian, Alec; Boutitie, Florent; Mewton, Nathan; Trochu, Jean‐Noël; Lefèvre, Thierry; Messika–Zeitoun, David; Guérin, Patrice; Cormier, Bertrand; Brochet, Éric; Thibault, Hélène; Himbert, Dominique; Thivolet, Sophie; Leurent, Guillaume; Bonnet, Guillaume; Donal, Erwan; Piriou, Nicolas; Piot, Christophe; Habib, Gilbert; Rouleau, Frédéric; Carrié, Didier; Nejjari, Mohammed; Ohlmann, Patrick; Saint Etienne, Christophe; Leroux, Lionel; Gilard, Martine; Samson, Géraldine; Rioufol, Gilles; Maucort‐Boulch, Delphine; François Obadia, Jean

doi:10.1002/ejhf.1616

Public

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 Years

Published in European Journal of Heart Failure • Sep 2, 2019

Authors:

Bernard Iung

Xavier Armoiry

Alec Vahanian

Abstract

AIMS: The MITRA-FR trial showed that among symptomatic patients with severe secondary mitral regurgitation, percutaneous repair did not reduce the risk of death or hospitalization for heart failure at 12 months compared with guideline-directed medical treatment alone. We report the 24-month outcome ...

Subject

Medicine

Percutaneous

Mitral regurgitation

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!